Safety and clinical activity of PD-L1 blockade in patients with aggressive recurrent respiratory papillomatosis

Overview of attention for article published in Journal for Immunotherapy of Cancer, May 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (59th percentile)

So far, Altmetric has seen 11 X posts from 8 X users, with an upper bound of 44,905 followers.

#JITC Research: Safety and clinical activity of PD-L1 blockade in patients with aggressive recurrent respiratory papillomatosis https://t.co/P7NiEsuuyv https://t.co/3Gm6nE6oNd

RT @sitcancer: #JITC Research: Safety and clinical activity of PD-L1 blockade in patients with aggressive recurrent respiratory papillomato…

RT @sitcancer: #JITC Research: Safety and clinical activity of PD-L1 blockade in patients with aggressive recurrent respiratory papillomato…

RT @sitcancer: #JITC Research: Safety and clinical activity of PD-L1 blockade in patients with aggressive recurrent respiratory papillomato…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 7 additional X posts.